Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Current Vascular Pharmacology|July 16, 2009
Future challenges for microsomal transport protein inhibitorsAnthony S Wierzbicki, Tim Hardman, William T PrinceAntimicrobial Agents and Chemotherapy|July 26, 2024
First-in-human, randomized, double-blind, placebo-controlled, single and multiple ascending doses clinical study to assess the safety, tolerability, and pharmacokinetics of cipargamin administered intravenously in healthy adultsVinay Kumar Venishetty, Jean Lecot, Amanda Nguyen, et al.The Journal of Antimicrobial Chemotherapy|April 6, 2019
Pharmacokinetics and tolerability of lefamulin following intravenous and oral dosingWolfgang W Wicha, William T Prince, Claudia Lell, et al.Clinical and Translational Science|September 9, 2023
Effects of triclabendazole and its metabolite exposure on the heart-rate-corrected QT intervals: A randomized, placebo- and positive-controlled thorough QT study in healthy individualsWilliam T Prince, Vinay Kumar Venishetty, Jean Lecot, et al.Journal of Clinical Pharmacology|August 7, 2002
Pharmacokinetics of GW433908, a prodrug of amprenavir, in healthy male volunteersChristine Falcoz, Julian M Jenkins, Carole Bye, et al.Journal of Clinical Pharmacology|November 5, 2021
Pharmacokinetics of Tropifexor, a Potent Farnesoid X Receptor Agonist, in Participants With Varying Degrees of Hepatic ImpairmentJin Chen, Jessie Gu, Bharti Shah, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 10, 2020
Safety, Pharmacokinetics, and Causal Prophylactic Efficacy of KAF156 in a Plasmodium falciparum Human Infection StudyJames G Kublin, Sean C Murphy, Janine Maenza, et al.Pageof 1